Suramin, a polysulphonated naphthylurea proven to be an effective anticancer agent against selected tumours, and cu2A-interferon (a2A-IFN) were investigated for their combined effects on HCT-8, HCT-15, CL-D, SW-480 and SW-620 human colorectal adenocarcinoma cell lines. All lines were sensitive to clinically achievable concentrations of suramin in a dose-dependent manner, while o2A-IFN alone induced only a modest reduction of cell growth. Concomitant treatment with suramin and o2A-IFN resulted in a synergistic inhibition of cell viability in each cell line at all doses tested. However, when suramin and o2A-IFN were administered sequentially, inhibition of cell viability was clearly dependent on the timing of treatment schedule, with maximum effect obtained when cw2A-IFN was administered prior to suramin. In contrast, pretreatment with suramin was markedly inferior to the former one. In conclusion, suramin and cu2A-IFN exert a synergistic effect on human colorectal cell proliferation in titro at clinically achievable concentrations. This observation may have clinical relevance although the mechanisms of interaction remain to be elucidated.

Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies / A. Falcone, R. Danesi, L. Zaccaro, D. Pieracci, E. Pfanner, C. Cianci, M. Andreuccetti, G. Malvaldi, M. DEL TACCA, P. Conte. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 30:4(1994), pp. 516-520. [10.1016/0959-8049(94)90429-4]

Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies

R. Danesi;
1994

Abstract

Suramin, a polysulphonated naphthylurea proven to be an effective anticancer agent against selected tumours, and cu2A-interferon (a2A-IFN) were investigated for their combined effects on HCT-8, HCT-15, CL-D, SW-480 and SW-620 human colorectal adenocarcinoma cell lines. All lines were sensitive to clinically achievable concentrations of suramin in a dose-dependent manner, while o2A-IFN alone induced only a modest reduction of cell growth. Concomitant treatment with suramin and o2A-IFN resulted in a synergistic inhibition of cell viability in each cell line at all doses tested. However, when suramin and o2A-IFN were administered sequentially, inhibition of cell viability was clearly dependent on the timing of treatment schedule, with maximum effect obtained when cw2A-IFN was administered prior to suramin. In contrast, pretreatment with suramin was markedly inferior to the former one. In conclusion, suramin and cu2A-IFN exert a synergistic effect on human colorectal cell proliferation in titro at clinically achievable concentrations. This observation may have clinical relevance although the mechanisms of interaction remain to be elucidated.
suramin; a-interferon; colorectal cancer; cell lines; in vitro
Settore BIOS-11/A - Farmacologia
1994
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1120627
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 9
social impact